The Oncology Institute, Inc. TOI Capitated revenue — Total operating revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s capitated revenue — total operating revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s capitated revenue — total operating revenue?
- The Oncology Institute, Inc. (TOI) reported capitated revenue — total operating revenue of $26.93M in Q1 2026.
- How has The Oncology Institute, Inc.'s capitated revenue — total operating revenue changed year-over-year?
- The Oncology Institute, Inc.'s capitated revenue — total operating revenue increased by 53.9% year-over-year, from $17.5M to $26.93M.
- What is the long-term trend for The Oncology Institute, Inc.'s capitated revenue — total operating revenue?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s capitated revenue — total operating revenue has grown at a 10.3% compound annual growth rate (CAGR), from $54.28M to $80.48M.
- What does capitated revenue — total operating revenue mean?
- This metric represents the total operating revenue generated specifically from capitated payment arrangements within the oncology service model. It reflects income derived from fixed, per-member-per-month fees paid by health plans or payers in exchange for providing comprehensive cancer care services. This revenue stream is a key indicator of the company's ability to manage population health risk and provide cost-effective oncology treatments under value-based care contracts.